News & HighlightsNews
DNA transcription is a tightly choreographed event. A new study reveals how it is choreographed.
A first-of-its-kind platform reveals how the molecular machine that turns DNA into RNA controls the speed of transcription.
This molecular switch helps cancer cells survive harsh conditions
When under cellular stress, breast cancer cells turn on genes that promote tumor growth and stress resistance.
There are countless species of bacteria scientists have never seen. This lab develops techniques that allow scientists to see them.
Their newest technique has already uncovered hundreds of hidden bacterial genomes and two promising antibiotics. Now, the same approach could unlock an entire microbial universe—reshaping drug discovery and our understanding of how bacteria shape our environment.
Hundreds of new bacteria, and two potential antibiotics, found in soil
Newly identified compounds appear effective against drug-resistant bacteria. The technique used to reveal them could uncover many more antibiotics, as well as help illuminate a previously hidden microbial world.
Researchers keep a mammalian cochlea alive outside the body for the first time
The technological breakthrough may improve our understanding of the cellular mechanisms behind hearing and its loss, which remain poorly understood.
New tool helps predict antibiotic resistance
Using the novel platform could help pharmaceutical companies design longer lasting drugs.
Rockefeller team finds flawed data in recent study relevant to coronavirus antiviral development
New research demonstrates that a previously published structure and mechanism for RNA capping at work in coronaviruses is incorrect, with potentially sweeping implications for the quest to develop drugs targeting these pathogens.
Novel method dramatically improves cryo-EM’s imaging capabilities
Researchers have devised a way to visualize molecules that are very rare, very small, or hard to produce naturally—including some viruses.
Svetlana Mojsov is elected to the National Academy of Sciences
Mojsov is a research associate professor whose research led to the development of drugs for obesity and diabetes.
Svetlana Mojsov honored with 2025 Breakthrough Prize
Mojsov is recognized for her discovery of the peptide hormone GLP-1, research that led to a new class of safe and highly effective drugs for type 2 diabetes as well as the treatment of obesity.
View
View